Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia
· Delayed Price · Currency is TND 9.15
+0.05 (0.55%)
At close: Mar 9, 2026
Unité de Fabrication des Médicaments S.A Company Description
Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic and fashioned medicines in Tunisia and internationally.
The company offers ophthalmic, ENT, inhalation and infusion solutions, injectable fluids and penicillin, and cephalosporin powders for various therapeutic areas under the UNIMED brand name.
It exports its products to Africa, Asia, and Europe. The company was founded in 1989 and is headquartered in Sousse, Tunisia.
Unité de Fabrication des Médicaments S.A
| Country | Tunisia |
| Founded | 1989 |
| Industry | Pharmaceutical Preparations |
| Employees | 572 |
| CEO | Ridha Charfeddine |
Contact Details
Address: Zone industrielle Kalâa Kebira Sousse, 4060 Tunisia | |
| Phone | 216 70 029 501 |
| Website | unimed.com.tn |
Stock Details
| Ticker Symbol | UMED |
| Exchange | Tunis Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TND |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ridha Charfeddine | Chief Executive Officer |
| Lotfi Charfeddine | Chief Financial Officer |